Syndax Pharmaceuticals (SNDX) Tops Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts SNDX Hot Sheet
Join SI Premium – FREE
Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q2 EPS of ($0.80), $0.11 better than the analyst estimate of ($0.91). Revenue for the quarter came in at $3.5 million.
For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi upgrades Bath & Body Works to Buy with $25 price target
- BofA Securities Reiterates Buy Rating on NVIDIA (NVDA)
- BofA Securities Downgrades Autohome Inc. (ATHM) to Underperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
